Unraveling the mechanisms of IVIG immunotherapy in MIS-C

In The Journal of Clinical Investigation, Zhu et al.(1) report that intravenous immunoglobulin (IVIG) targets IL-1β(+) neutrophils to exert anti-inflammatory effects in multisystem inflammatory syndrome in children (MIS-C), a post-infectious inflammatory condition associated with COVID-19.

Detalles Bibliográficos
Autores principales: Ganigara, Madhusudan, Sharma, Chetan, Bayry, Jagadeesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Spotlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481087/
https://www.ncbi.nlm.nih.gov/pubmed/34608458
http://dx.doi.org/10.1016/j.xcrm.2021.100431
_version_ 1784576605550542848
author Ganigara, Madhusudan
Sharma, Chetan
Bayry, Jagadeesh
author_facet Ganigara, Madhusudan
Sharma, Chetan
Bayry, Jagadeesh
author_sort Ganigara, Madhusudan
collection PubMed
description In The Journal of Clinical Investigation, Zhu et al.(1) report that intravenous immunoglobulin (IVIG) targets IL-1β(+) neutrophils to exert anti-inflammatory effects in multisystem inflammatory syndrome in children (MIS-C), a post-infectious inflammatory condition associated with COVID-19.
format Online
Article
Text
id pubmed-8481087
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84810872021-09-30 Unraveling the mechanisms of IVIG immunotherapy in MIS-C Ganigara, Madhusudan Sharma, Chetan Bayry, Jagadeesh Cell Rep Med Spotlight In The Journal of Clinical Investigation, Zhu et al.(1) report that intravenous immunoglobulin (IVIG) targets IL-1β(+) neutrophils to exert anti-inflammatory effects in multisystem inflammatory syndrome in children (MIS-C), a post-infectious inflammatory condition associated with COVID-19. Elsevier 2021-09-30 /pmc/articles/PMC8481087/ /pubmed/34608458 http://dx.doi.org/10.1016/j.xcrm.2021.100431 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Spotlight
Ganigara, Madhusudan
Sharma, Chetan
Bayry, Jagadeesh
Unraveling the mechanisms of IVIG immunotherapy in MIS-C
title Unraveling the mechanisms of IVIG immunotherapy in MIS-C
title_full Unraveling the mechanisms of IVIG immunotherapy in MIS-C
title_fullStr Unraveling the mechanisms of IVIG immunotherapy in MIS-C
title_full_unstemmed Unraveling the mechanisms of IVIG immunotherapy in MIS-C
title_short Unraveling the mechanisms of IVIG immunotherapy in MIS-C
title_sort unraveling the mechanisms of ivig immunotherapy in mis-c
topic Spotlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481087/
https://www.ncbi.nlm.nih.gov/pubmed/34608458
http://dx.doi.org/10.1016/j.xcrm.2021.100431
work_keys_str_mv AT ganigaramadhusudan unravelingthemechanismsofivigimmunotherapyinmisc
AT sharmachetan unravelingthemechanismsofivigimmunotherapyinmisc
AT bayryjagadeesh unravelingthemechanismsofivigimmunotherapyinmisc

Ejemplares similares